Senior insider sale
Chief Technical Ops Officer at PTC THERAPEUTICS, INC. — senior position signals high conviction
$8.46M
110.17K shares
What this filing means
ALMSTEAD NEIL GREGORY plans to sell 110.17K shares of PTC THERAPEUTICS, INC. valued at approximately $8.46M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/26/2026ACC: 0001959173-26-004919
Officer· Chief Technical Ops Officer
Since Jan 2019
110.17K
Shares to sell
$8.46M
Approx. market value
8.13K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
6/26/2026
8.13KTotal acquired8.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/26/2026 | Stock Option Exercise Cash | 8.13K | — |
| Total | 8.13K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
20.96K
Market value
$1.80M
6/25/2026
—Completed
Units to sell
5.32K
Market value
$452.6K
6/24/2026
—Completed
Units to sell
23.75K
Market value
$1.92M
6/22/2026
—Completed
Units to sell
52K
Market value
$3.59M
4/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.13K
Market value
$693.1K
6/26/2026
Total
Units
110.17K
Value
$8.46M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2026 | 20.96K | $1.80M | — | Completed |
6/24/2026 | 5.32K | $452.6K | — | Completed |
6/22/2026 | 23.75K | $1.92M | — | Completed |
4/1/2026 | 52K | $3.59M | — | Completed |
| Planned — Approximate Date | ||||
6/26/2026 | 8.13K | $693.1K | NASDAQ | Planned |
| Total | 110.17K | $8.46M | ||